Nov. 2016. Wondaleaf was showcased to UNFPA officials in a conference at United Nation in Bangkok. The pivotal meeting also led to Wondaleaf’s clinical trial in South Africa in 2017. The functional performance study conducted by MatCH has now been completed. The favourable results will be published in due course.